Drug development
Today, the Center for Translational Research (CTR) announced three major internal leadership changes within the corporate group. These changes mean that Anna Steneholm becomes the new CEO of Toxicology Knowledge Team Sweden AB (TKT). Current CEO Suzanne Iverson Hemberg will become the new CEO at sister company CTC Clinical Trial Consultants (CTC). CTC’s current CEO, Anders Millerhovf, will in turn take a dual position as Chief Commercial Officer at CTC and CTR.
“These leadership transitions mark the next step in our journey, building on a proven record of growth, trust and customer value. As demand for our expertise and specialized services continues to rise, we will expand our capabilities to deliver even greater value to customers and partners. I am proud of our internal talents and grateful for the opportunity to foster leadership through internal career development,” says Karin Meyer, the CEO of TKT’s holding company CTR.
Anna has worked as Senior Toxicology Consultant at TKT since 2022 and holds a PhD in Toxicology from Karolinska Institutet. She has previously held senior roles within toxicology in the chemical and petroleum industry, for example with the trade organisation Concawe and Nynas AB.
“It’s exciting to take the step from specialist to CEO at TKT! Having an opportunity to lead such a competent and passionate team, which is set to grow in the coming years, feels incredibly inspiring. I look forward to our team’s continued contribution to the safety of pharmaceutical and chemical products, maintaining the same high quality, scientific curiosity, and integrity that’s the hallmark of the TKT team,” Anna says.
Suzanne has been TKT’s CEO since 2022, and will continue her involvement in TKT as a member of the board.
“Leaving my fantastic colleagues at TKT Sweden and following Anders as CEO of CTC are both challenging endeavours. As the new CEO of CTC, I am looking forward to combining my passion for the science behind development of safe and effective therapeutics with my energy, drive and solid track record in leading in a complex environment,” Suzanne says.
These role changes will take effect during the last quarter of this year.